Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: A report from the childrens cancer study group-Reference-Cited by-同舟云学术

Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: A report from the childrens cancer study group

Published:1989 Issue:5-6 Volume:17 Page:382-390
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Buckley Jonathan D.,Lampkin Beatrice C.,Nesbit Mark E.,Bernstein Irwin D.,Feig Stephen A.,Kersey John H.,Piomelli Sergio,Kim Tae,Hammond G. Denman

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mpo.2950170507/fullpdf

Reference23 articles.

1. Improved treatment results in childhood acute myelogenous leukemia: A report of the German cooperative study AML-BFM-78;Creutzig;Blood,1985

2. Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia;Dahl;Blood,1982

3. Treatment of acute myelogenous leukemia in children and adults;Weinstein;N Engl J Med,1980

4. Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update;Weinstein;Blood,1983

5. Current status of the biology and treatment of acute non-lymphocytic leukemia in children (Report from the ANLL Strategy Group of the Children's Cancer Study Group);Lampkin;Blood,1983

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer;Nature Medicine;2023-09

2. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas;Biomedicine & Pharmacotherapy;2021-08

3. Improved chemotherapy modeling with RAG-based immune deficient mice;PLOS ONE;2019-11-20

4. A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML;Clinical Epigenetics;2017-10-05

5. A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML;2017-06-14